Literature DB >> 28342833

A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.

Nina K Jain1, Susan Barkowski-Clark1, Richard Altman1, Krista Johnson1, Fang Sun1, Jonathan Zmuda2, Chao Yan Liu2, Adriana Kita1, Ryan Schulz1, Alyssa Neill1, Robert Ballinger1, Rekha Patel1, Jian Liu2, Alinafe Mpanda2, Brian Huta1, Henry Chiou2, Walter Voegtli1, Tadas Panavas3.   

Abstract

Chinese Hamster Ovary (CHO) cells are the principal mammalian host used for stable cell line generation and biotherapeutic protein production. Until recently, production of milligrams to grams of protein in CHO transient systems was challenging. As such, Human Embryonic Kidney (HEK293) cells are the most common mammalian cell type used for transient transfection. The post-translational modifications (PTMs) of a protein are dictated in part by the cell line used for expression, and changes in PTMs have been shown to affect both the activity and biophysical properties of proteins. Therefore, it is potentially advantageous to keep the host cell type consistent throughout drug discovery and development. To this end, we compared the ExpiCHO system, a high density CHO-S transient transfection system, to the Expi293 and FreeStyle MAX CHO transient systems. Fourteen proteins were expressed in both the Expi293 and ExpiCHO systems. For a majority of proteins tested, the protein titers observed with the ExpiCHO system were higher than those seen with both the FreeStyle MAX CHO and Expi293 systems. Antibodies expressed using the ExpiCHO system had glycosylation patterns more similar to antibodies produced in stable CHO cell lines than Expi293-derived antibodies. However, culture duration and temperature were found to affect protein titer, monodispersity, enzyme activity, and PTMs and should be carefully selected when using the ExpiCHO system. The ExpiCHO transient transfection systems allows for facile production of milligrams to grams of protein in CHO cells and de-risks the transition from transient to stable material during drug development.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHO cells; Glycosylation; HEK293 cells; Post-translational modification; Transient transfection

Mesh:

Substances:

Year:  2017        PMID: 28342833     DOI: 10.1016/j.pep.2017.03.018

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  17 in total

Review 1.  New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics.

Authors:  Dominic Esposito; Andrew G Stephen; Thomas J Turbyville; Matthew Holderfield
Journal:  Semin Cancer Biol       Date:  2018-02-09       Impact factor: 15.707

2.  Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice.

Authors:  Jiahong Sun; Ruben J Boado; William M Pardridge; Rachita K Sumbria
Journal:  Mol Pharm       Date:  2019-06-27       Impact factor: 4.939

Review 3.  Structural Analysis of Recent Allergen-Antibody Complexes and Future Directions.

Authors:  Geoffrey A Mueller; Jungki Min; Alexander C Y Foo; Anna Pomés; Lars C Pedersen
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 4.  Progress of cationic gene delivery reagents for non-viral vector.

Authors:  Kai Ma; Chun-Liu Mi; Xiang-Xiang Cao; Tian-Yun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

5.  Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins.

Authors:  James Warren; Michelle Im; Angela Ballesteros; Cam Ha; Tom Moore; Fanny Lambert; Sophie Lucas; Boris Hinz; Gabriela Dveksler
Journal:  Mol Hum Reprod       Date:  2018-12-01       Impact factor: 4.025

6.  Heterologous expression of plant glycosyltransferases for biochemistry and structural biology.

Authors:  Pradeep K Prabhakar; Hsin-Tzu Wang; Peter J Smith; Jeong-Yeh Yang; William J Barnes; Maria J Peña; Kelley W Moremen; Breeanna R Urbanowicz
Journal:  Methods Cell Biol       Date:  2020-06-13       Impact factor: 1.441

7.  Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.

Authors:  Dominic Esposito; Jennifer Mehalko; Matthew Drew; Kelly Snead; Vanessa Wall; Troy Taylor; Peter Frank; John-Paul Denson; Min Hong; Gulcin Gulten; Kaitlyn Sadtler; Simon Messing; William Gillette
Journal:  Protein Expr Purif       Date:  2020-06-04       Impact factor: 1.650

8.  Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells.

Authors:  Albert Cupo; Victor M Cruz Portillo; Paul Gelfand; Anila Yasmeen; P J Klasse; John P Moore
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

9.  Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques.

Authors:  June Ereño-Orbea; Taylor Sicard; Hong Cui; Indira Akula; Jean-Philippe Julien
Journal:  J Vis Exp       Date:  2018-07-05       Impact factor: 1.355

10.  Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.

Authors:  Georgia Bullen; Jacob D Galson; Gareth Hall; Pedro Villar; Lien Moreels; Line Ledsgaard; Giada Mattiuzzo; Emma M Bentley; Edward W Masters; David Tang; Sophie Millett; Danielle Tongue; Richard Brown; Ioannis Diamantopoulos; Kothai Parthiban; Claire Tebbutt; Rachael Leah; Krishna Chaitanya; Sandra Ergueta-Carballo; Deividas Pazeraitis; Sachin B Surade; Omodele Ashiru; Lucia Crippa; Richard Cowan; Matthew W Bowler; Jamie I Campbell; Wing-Yiu Jason Lee; Mark D Carr; David Matthews; Paul Pfeffer; Simon E Hufton; Kovilen Sawmynaden; Jane Osbourn; John McCafferty; Aneesh Karatt-Vellatt
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.